April 02, 2026 02:11 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Bengal SIR progress: 47 lakh of 60 lakh adjudicated cases disposed of, Supreme Court informed | Amit Shah to join Suvendu Adhikari on Bhabanipur nomination day; BJP plans mega roadshow | Fuel prices rise: Premium petrol, diesel hiked amid oil price surge | Commercial LPG up Rs 195.50 as global oil prices rise; domestic rates unchanged | Layoff alert: Oracle cuts 30,000 jobs globally, 12,000 hit in India | ‘Unsubstantial allegations’: Calcutta HC dismisses plea on ECI’s officer transfers in Bengal | Tennis icon Leander Paes joins BJP ahead of Bengal polls | 8 killed, several injured in crowd crush at Bihar temple in Nalanda | Trump signals exit from Iran war even as Strait of Hormuz remains shut: Report | Mystery death in Pakistan: JeM chief Masood Azhar’s brother found dead
Moderna

Moderna Covid-19 vaccine likely to protect for 'couple of years': CEO Stephane Bancel

| @indiablooms | Jan 08, 2021, at 05:40 am

Paris/IBNS: Moderna's COVID-19 mRNA vaccine is expected to offer protection of up to a couple of years, the US biotech's chief executive said on Thursday.

The US biotech company, which came up with a vaccine last year against the novel coronavirus in just a few weeks, received approval for its shot from the European Commission on Wednesday, reports said.

Speaking at an event, organised by financial services group Oddo BHF, Moderna CEO Stephane Bancel said: "The nightmare scenario that was described in the media in the spring with a vaccine only working a month or two is, I think, out of the window."

"The antibody decay generated by the vaccine in humans goes down very slowly (...) We believe there will be protection potentially for a couple of years," he said, as reported by Reuters.

Bancel said his country is working to prove that its vaccine would also be effective against variants of the coronavirus seen in Britain and South Africa.

Scientists claim that the newly developed vaccines should be effective against both variants.

 

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.